• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBJR062502A
Device Problems Improper or Incorrect Procedure or Method (2017); Activation Failure (3270)
Patient Problem Occlusion (1984)
Event Date 11/14/2019
Event Type  malfunction  
Manufacturer Narrative
Review of the manufacturing records verified that the lot met release requirements.The investigation is ongoing.Note: the gore® viabahn® endoprosthesis instructions for use state: w.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore® viabahn® endoprosthesis in applications where the device is deployed within stents or stent grafts other than the gore® viabahn® endoprosthesis.Other devices may interfere with the deployment of the gore® viabahn® endoprosthesis resulting in deployment failure or other device malfunction.
 
Event Description
The following was reported to gore by the doctor: the pad patient presented for sfa repair.The gore® viabahn® endoprosthesis was advanced through a previously deployed bare metal stent.The deployment line was pulled and approximately 1cm of the gore® viabahn® endoprosthesis deployed but deployment stopped.The doctor exerted great tension on the deployment line with no progress.As the doctor continued to pull the deployment line the device appeared to bow.The doctor was able to withdraw the partially deployed device into the sheath and removed both together from the patient.
 
Manufacturer Narrative
Additional manufacturer narrative: examination of the returned device revealed the following: the entire device was returned; there was approximately 55 cm of deployment line between the hub and deployment knob; the endoprosthesis was partially expanded approximately 1.5 cm at the tip end of the endoprosthesis; there was delamination in the body of the endoprosthesis; the remainder of the endoprosthesis was still constrained; the distal shaft, upon which the endoprosthesis is mounted, appeared to be bowstrung; deployment was not able to be continued with traction on the deployment line at the endoprosthesis.Upon further inspection, there appeared to be a broken fiber near the location that deployment stopped.The remainder of the device was unremarkable.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9364054
MDR Text Key193653337
Report Number2017233-2019-01179
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132623976
UDI-Public00733132623976
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/23/2022
Device Catalogue NumberVBJR062502A
Device Lot Number21014645
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-